These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25651685)

  • 1. [Chronic hepatitis C. Something new].
    Sabourin G
    Perspect Infirm; 2015; 12(1):60. PubMed ID: 25651685
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new era in therapy of chronic hepatitis C].
    Füessl HS
    MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
    [No Abstract]   [Full Text] [Related]  

  • 3. [New combination therapy increases chances of recovery].
    Jäger-Becker D
    MMW Fortschr Med; 2015 Feb; 157(3):70. PubMed ID: 25743682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
    Einecke D
    MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].
    MMW Fortschr Med; 2014 Dec; 156(21-22):97. PubMed ID: 25608420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():53. PubMed ID: 25026860
    [No Abstract]   [Full Text] [Related]  

  • 7. Special report: cost-effectiveness studies of new hepatitis C treatments.
    Mark DH;
    Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
    [No Abstract]   [Full Text] [Related]  

  • 8. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
    [No Abstract]   [Full Text] [Related]  

  • 9. Sovaldi ushers in wave of costly hepatitis C drugs.
    Manag Care; 2014 Jan; 23(1):51. PubMed ID: 24765752
    [No Abstract]   [Full Text] [Related]  

  • 10. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
    Ollendorf DA; Tice JA; Pearson SD
    JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing a broader user base for new HCV drug.
    Sekkides O
    Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon free recovery for almost all patients].
    Einecke D
    MMW Fortschr Med; 2015 Mar; 157(4):71. PubMed ID: 25743991
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.
    Canary LA; Klevens RM; Holmberg SD
    Ann Intern Med; 2015 Aug; 163(3):226-8. PubMed ID: 26121095
    [No Abstract]   [Full Text] [Related]  

  • 14. Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.
    Liao JM; Fischer MA
    N Engl J Med; 2015 Sep; 373(13):1279-81. PubMed ID: 26398092
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic viral hepatitis. Treatment progress, hopes for cures.
    Mayo Clin Health Lett; 2014 Mar; 32(3):4-5. PubMed ID: 24696905
    [No Abstract]   [Full Text] [Related]  

  • 16. The rapid evolution of treatment strategies for hepatitis C.
    Muir AJ
    Am J Gastroenterol; 2014 May; 109(5):628-35; quiz 636. PubMed ID: 24732866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Healing rate after 12 weeks over 90% for the first time].
    Warpakowski A
    MMW Fortschr Med; 2015 Apr; 157(6):72. PubMed ID: 26015221
    [No Abstract]   [Full Text] [Related]  

  • 18. Incorporating patient-reported outcomes into hepatitis C virus treatment studies.
    Evon DM
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1360-2. PubMed ID: 24534544
    [No Abstract]   [Full Text] [Related]  

  • 19. Building bridges and providing transparency to the hepatitis C virus drug approval process.
    Ghany MG; Liang TJ
    Gastroenterology; 2014 Dec; 147(6):1201-3. PubMed ID: 25449025
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond sofosbuvir: what opportunity exists for a better nucleoside/nucleotide to treat hepatitis C?
    Sofia MJ
    Antiviral Res; 2014 Jul; 107():119-24. PubMed ID: 24792751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.